Price - to - Earnings Ratio
Search documents
5 Undervalued Price-to-Book Stocks to Consider for Your Portfolio
ZACKS· 2026-03-23 14:45
Core Insights - Investors often focus on valuation metrics such as Price-to-Earnings (P/E) and Price-to-Sales (P/S) ratios to assess a company's valuation [1] - The Price-to-Book (P/B) ratio is also a valuable tool for identifying undervalued stocks with growth potential, comparing market value to book value [2] Valuation Metrics - The P/E ratio measures annual earnings relative to stock price, while the P/S ratio indicates the price investors pay for each dollar of revenue [1] - The P/B ratio is calculated as market capitalization divided by shareholders' equity, helping to identify attractively priced stocks [2][6] - A P/B ratio of less than one suggests a stock is undervalued, while a ratio greater than one indicates it may be overvalued [6][7] Company Examples - Sanmina (SANM) is highlighted as a low P/B stock with a projected EPS growth rate of 26% [12][17] - Mistras Group (MG) shows a projected EPS growth of 16% and has a Zacks Rank of 1 [12][18] - Strategic Education (STRA) has a projected EPS growth rate of 15% and a Zacks Rank of 2 [12][19] - Patria Investments Limited (PAX) has a projected EPS growth rate of 15.76% and a Zacks Rank of 2 [12][20] - Nexa Resources (NEXA) stands out with a projected EPS growth of 51.17% and a Zacks Rank of 1 [12][21] Screening Parameters - Stocks with a P/B ratio lower than the industry median are considered attractive for potential gains [13] - A lower P/S ratio compared to the industry average makes a stock more appealing [13] - A P/E ratio lower than the industry median is viewed favorably [14] - A PEG ratio of less than 1 indicates undervaluation with strong growth prospects [15] - Stocks must have a current price of at least $5 and an average 20-day volume of 100,000 for better tradability [16]
5 Low P/B Ratio Stocks That You May Consider Buying in March
ZACKS· 2026-03-06 14:22
Core Insights - The article discusses the importance of various valuation metrics, particularly the price-to-book (P/B) ratio, in identifying low-priced stocks with high-growth potential [1][5][9] Valuation Metrics - Price-to-earnings (P/E) and price-to-sales (P/S) ratios are commonly used for stock selection, while the P/B ratio is also effective for identifying undervalued stocks [1][5] - The P/B ratio is calculated as market capitalization divided by book value of equity, helping to assess whether a stock is under- or overvalued [2][5] Book Value - Book value represents the total value left for shareholders if a company were to liquidate its assets after settling liabilities, calculated by subtracting total liabilities from total assets [3][4] P/B Ratio Analysis - A P/B ratio of less than one indicates that a stock is trading below its book value, suggesting it may be undervalued [5] - Conversely, a P/B ratio greater than one may indicate overvaluation, but could also suggest the stock is a takeover target [7] Limitations of P/B Ratio - The P/B ratio is particularly useful for companies in finance, investments, and manufacturing but may be misleading for firms with high R&D expenditures or negative earnings [8] Stock Picks - Ford, USANA Health Sciences, Strategic Education, Patria Investments, and Concentrix are highlighted as low P/B stock picks with strong growth potential [9][15][16][17][18][19] - Ford has a projected 3-5 year EPS growth rate of 27.4% and a Zacks Rank of 2 [15] - USANA Health Sciences has a projected EPS growth rate of 12.0% and a Zacks Rank of 1 [16] - Strategic Education has a projected EPS growth rate of 15% and a Zacks Rank of 1 [17] - Patria Investments has a projected EPS growth rate of 15.76% and a Zacks Rank of 2 [18] - Concentrix has a projected EPS growth rate of 8.76% and a Zacks Rank of 2 [19]
P/E Ratio Insights for Keurig Dr Pepper - Keurig Dr Pepper (NASDAQ:KDP)
Benzinga· 2026-03-04 21:00
Core Viewpoint - Keurig Dr Pepper Inc. has experienced a short-term stock increase but shows a significant long-term decline, prompting a review of its price-to-earnings ratio for long-term investors [1] Group 1: Stock Performance - The current share price of Keurig Dr Pepper Inc. is $29.59, reflecting a 1.98% drop in the current market session [1] - Over the past month, the stock has increased by 1.88%, but it has decreased by 13.56% over the past year [1] Group 2: Price-to-Earnings Ratio Analysis - The price-to-earnings (P/E) ratio is a critical metric for long-term investors, comparing the current share price to the company's earnings per share (EPS) [2] - A higher P/E ratio suggests that investors expect better future performance, which may indicate overvaluation or optimism about future dividends [2] Group 3: Industry Comparison - Keurig Dr Pepper Inc. has a P/E ratio of 19.33, which is lower than the aggregate P/E ratio of 60.21 for the Beverages industry [3] - This lower P/E ratio may lead shareholders to believe that the stock could perform worse than its industry peers, or it may indicate that the stock is undervalued [3]
Southern Copper Corporation (NYSE:SCCO) Insider Sale and Analyst Ratings
Financial Modeling Prep· 2026-03-03 00:00
Core Viewpoint - Southern Copper Corporation is a significant player in the mining industry, primarily focused on copper production, and operates in Peru and Mexico, making it one of the largest integrated copper producers globally [1] Company Overview - Southern Copper Corporation (NYSE:SCCO) is engaged in the production of copper, molybdenum, zinc, and silver [1] - The company faces competition from major players like Freeport-McMoRan and BHP Group in the copper mining sector [1] Insider Transactions - On March 2, 2026, a director at Southern Copper sold 4,587 shares at $217.39 each, leaving him with 600 shares, which may indicate insights into the company's future performance or personal financial planning [2][6] Analyst Ratings - The stock has received a consensus "Reduce" rating from thirteen ratings firms, with eight analysts issuing a "sell" rating, three a "hold" rating, and two a "buy" rating [3] - Recent evaluations show a cautious outlook, with Scotiabank reaffirming an "underperform" rating, Zacks Research downgrading from "strong-buy" to "hold," and UBS Group maintaining a "sell" rating with a price target adjustment to $148.74 [4] Financial Metrics - Southern Copper has a price-to-earnings (P/E) ratio of 42.01, indicating that investors are paying a premium for earnings [5] - The company's price-to-sales ratio is 13.37, and its enterprise value to sales ratio is 13.60, reflecting its market valuation [5] - An earnings yield of 2.38% suggests moderate profitability, while a debt-to-equity ratio of 0.66 indicates a balanced approach to leveraging debt [5] - The current ratio of 3.89 demonstrates strong liquidity [5][6]
Understanding Arcellx Inc (ACLX)'s Financial Health and Market Position
Financial Modeling Prep· 2026-02-26 10:13
Company Overview - ACLX (NASDAQ:ACLX) is currently facing financial challenges, indicated by a negative price-to-earnings (P/E) ratio of -29.54, which signifies that the company is not profitable at this time [1][6] - The company maintains a low debt-to-equity ratio of 0.12, reflecting a conservative approach to leveraging debt [1][6] Financial Metrics - The price-to-sales ratio for ACLX is notably high at 183.24, suggesting that investors are willing to pay a premium for the company's sales [3][6] - The enterprise value to sales ratio stands at 182.48, indicating high market expectations for ACLX's growth trajectory despite its current profitability challenges [3] - Further analysis reveals a negative enterprise value to operating cash flow ratio of -33.07 and a negative earnings yield of -3.38%, highlighting the financial hurdles faced by ACLX [4] - However, the company has a strong current ratio of 3.99, indicating solid short-term financial health and liquidity [4] Market Context - In the broader biotech sector, Gilead Sciences' acquisition of Arcellx Inc. for $7.8 billion, or $115 per share in cash, underscores the competitive landscape and high stakes involved [5] - This acquisition aims to enhance Gilead's oncology portfolio with promising therapies, setting a significant benchmark for ACLX in the market [5] - Despite these developments, ACLX's stock has shown a short-term bearish trend, trading below its 20-day and 100-day simple moving averages [5]
EnWave Corporation's Financial Performance and Market Position
Financial Modeling Prep· 2026-02-20 23:00
Core Insights - EnWave Corporation reported earnings per share of -$0.01, missing market expectations, indicating financial challenges [1][2] - The company generated revenue of approximately $1.6 million in Q1 2026, a 36% increase from the previous year's $1.177 million, attributed to large-scale machine sales and increased royalties [3][4] - Despite negative earnings, the price-to-sales ratio of about 2.97 suggests some investor confidence [4] Financial Performance - The trailing price-to-earnings (P/E) ratio is approximately -25, reflecting ongoing financial difficulties [3] - Revenue fell short of the estimated $3.72 million, highlighting performance challenges [3] - Total royalty revenue for Q1 2026 reached $627,000, a 12% increase from the previous year, driven by increased production and sales activities from royalty partners [4] Operational Metrics - The gross margin expanded to 37%, up from 29% in the prior year, due to higher royalties and an optimized production mix [3] - The enterprise value to sales ratio is approximately 2.68, indicating the company's valuation in relation to sales [4] - The debt-to-equity ratio is about 0.27, suggesting a relatively low level of debt compared to equity [4] - A current ratio of approximately 3.48 indicates a strong ability to cover short-term liabilities with short-term assets [4]
Lamar Advertising Company (NASDAQ:LAMR) Earnings Report Overview
Financial Modeling Prep· 2026-02-20 19:03
Core Insights - Lamar Advertising Company reported an EPS of $1.50, which fell short of the estimated $2.18, but its revenue of approximately $596 million slightly exceeded the estimated $593 million [1][6] Financial Performance - The company reported quarterly funds from operations (FFO) of $2.24 per share, surpassing the Zacks Consensus Estimate of $2.18 per share, marking a 2.75% FFO surprise [2][6] - For the quarter ending December 2025, Lamar's revenues of $596 million represented a 2.5% increase from $579.57 million in the same period last year, despite falling short of the Zacks Consensus Estimate by 0.24% [3] - Over the past year, Lamar achieved net revenues of $2.27 billion, with a net income of $593.1 million and an adjusted EBITDA of $1.06 billion [3] Management Outlook - CEO Sean Reilly expressed optimism about the company's performance, citing strong sales momentum in both local and national markets, and projected a full-year diluted AFFO per share range between $8.50 and $8.70 [4][6] Valuation Metrics - Lamar has a price-to-earnings (P/E) ratio of approximately 22.91, a price-to-sales ratio of about 5.95, an enterprise value to sales ratio of around 5.92, and an enterprise value to operating cash flow ratio of approximately 15.52 [5]
Hudbay Minerals Inc. (NYSE:HBM) Earnings Preview: A Look at Upcoming Financial Performance
Financial Modeling Prep· 2026-02-19 10:00
Core Viewpoint - Hudbay Minerals Inc. is expected to report significant earnings growth driven by higher revenues, effective cost management, and strong gold prices, with analysts projecting an EPS of $0.41, up from $0.18 the previous year, marking a 122% increase [2]. Financial Performance - The projected revenue for Hudbay for the upcoming quarter is approximately $746.3 million, indicating a year-over-year growth of 30.6%, supported by deferred copper shipments and strong production output in October [3]. - The company has a history of exceeding earnings expectations, having done so in two of the last four quarters, with an average earnings surprise of 40.68% [3]. Valuation Metrics - Hudbay's price-to-earnings (P/E) ratio stands at 21.45, reflecting the price investors are willing to pay for each dollar of earnings [4]. - The price-to-sales ratio is 4.79, and the enterprise value to sales ratio is 5.03, indicating the company's valuation relative to its sales [4]. Debt and Liquidity - The debt-to-equity ratio for Hudbay is 0.36, suggesting a moderate level of debt compared to equity [5]. - The current ratio is 0.97, indicating the company's ability to cover short-term liabilities with short-term assets [5]. - The earnings yield is 4.66%, representing the return on investment for shareholders [5].
BAE Systems' Financial Performance and Market Position
Financial Modeling Prep· 2026-02-18 19:00
Core Viewpoint - BAE Systems, a significant player in the defense industry, reported earnings that were slightly below estimates, yet the company's shares rose due to investor confidence in its long-term growth prospects [2][6]. Financial Performance - The company reported an earnings per share (EPS) of $0.52, which was below the estimated EPS of $0.54 [2][6]. - Actual revenue was approximately $21.64 billion, falling short of the estimated $21.77 billion, but showed a year-on-year sales increase of 10%, reaching a record £30.7 billion ($41.7 billion) [3][6]. Growth Drivers - The growth in sales was driven by significant defense contracts with countries such as Norway, the U.S., and Turkey, as noted by CEO Charles Woodburn [3]. Financial Metrics - BAE Systems has a price-to-earnings (P/E) ratio of approximately 31.54, indicating the price investors are willing to pay for each dollar of earnings [4][6]. - The price-to-sales ratio stands at about 2.19, and the enterprise value to sales ratio is around 2.46, reflecting the company's total value compared to its sales [4]. Order Backlog and Future Outlook - The company's order backlog has reached £83.6 billion, marking a £5.8 billion increase from 2024 [5]. - BAE Systems anticipates sales growth of 7% to 9% in 2026, with projected cumulative free cash flow exceeding £6 billion between 2026 and 2028 [5]. - The debt-to-equity ratio is approximately 0.87, suggesting a balanced approach to financing its growth and operations [5][6].
Walmart Q4 Preview: Investors Should Fade Retailer, Market Expert Says Rally 'Priced Into The Stock'
Benzinga· 2026-02-18 17:21
Core Viewpoint - Walmart is expected to report strong fourth-quarter earnings, with revenue projected at $189.18 billion, an increase from $180.55 billion in the same quarter last year, and earnings per share anticipated to rise to 73 cents from 66 cents [2][3]. Earnings Estimates - Analysts predict Walmart's fourth-quarter revenue will be $189.18 billion, marking a year-over-year increase of approximately 4.5% [2]. - The expected earnings per share for the fourth quarter is 73 cents, up from 66 cents in the previous year [2]. Analyst Insights - Walmart has consistently exceeded revenue estimates for over 15 consecutive quarters and earnings estimates in seven of the last eight quarters [2][3]. - Market experts suggest that while Walmart's stock may perform well post-earnings, it may not sustain a rally due to high expectations already priced into the stock [4]. - Walmart's price-to-earnings ratio is noted to be 46, higher than most of the "Magnificent Seven" stocks, indicating a premium valuation [5]. CEO Transition - The upcoming earnings report will be the first under new CEO John Furner, with expectations of continued market share gains and stable comparable sales growth in the 4%-5% range [6]. Recent Performance - Walmart has shown consistent U.S. comparable sales growth in the range of 4.5%-4.8% over the last four quarters [7]. - The company's international sales have also seen a year-over-year increase of 10.8% [8]. Key Items to Watch - Investors are keen to see how consumer spending trends are reflected in the earnings report, particularly whether there is a shift from name-brand to private-label products [8]. - Strong growth in both U.S. and international segments, along with positive guidance for the next fiscal year, is anticipated to impact major stock market indexes and consumer staple ETFs significantly [9]. Stock Performance - As of the latest report, Walmart's stock is trading at $128.63, down 0.2%, with a year-to-date increase of 14.1% and a 52-week increase of 23.9% [11].